CD Biosynsis offers specialized Chlamydomonas reinhardtii Gene Knockout Services, providing permanent and precise disruption of target genes in this premier model photosynthetic alga. Gene knockout in Chlamydomonas is a critical tool for identifying gene functions related to photosynthesis, carbon concentrating mechanisms (CCM), and flagellar dynamics. Leveraging optimized CRISPR-Cas9 Ribonucleoprotein (RNP) delivery, our services overcome the common challenges of high GC-content and transgene silencing. We provide end-to-end solutions, from expert gRNA design to the delivery of verified monoclonal knockout strains, accelerating your research in algal biotechnology and fundamental plant biology.
Get a QuoteTraditional gene disruption in Chlamydomonas often relied on random insertional mutagenesis, which lacks precision and leads to complex background mutations. Our CRISPR-Cas9 platform utilizes DNA-free Ribonucleoprotein (RNP) complexes to induce targeted double-strand breaks (DSBs). The cell's endogenous Non-Homologous End Joining (NHEJ) pathway repairs these breaks, resulting in small insertions or deletions (indels) that create frameshift mutations. This RNP-based approach is particularly effective for Chlamydomonas because it bypasses the nuclear integration of Cas9 DNA, thereby avoiding the host's robust gene silencing machinery and reducing the risk of long-term off-target effects.
To achieve high-efficiency gene disruption in the challenging algal genome, we offer a diversified range of knockout strategies tailored to specific research goals.
Exon-Targeted Indels
Targeting the first or second exon with high-specificity gRNAs to induce frameshift mutations. This ensures the early termination of translation and complete loss of functional domains.
Dual-gRNA Fragment Deletion
Simultaneous delivery of two gRNAs targeting the 5' and 3' ends of a gene or specific domain. This results in the excision of large genomic fragments, making the knockout more robust and easier to screen via PCR.
GC-Optimized Cas9/Cas12a
Selection of nuclease variants with modified PAM requirements to navigate the 64% GC-rich regions of the Chlamydomonas nucleus, expanding the range of targetable sites.
Photosystem Disruption
Targeting chloroplast-encoded genes (e.g., psbA, rbcL) to study the assembly and regulation of the photosynthetic apparatus without nuclear interference.
Biolistic Gene Gun Delivery
Utilizing micro-projectile bombardment for direct delivery of editing tools into the cup-shaped chloroplast, bypassing nuclear transport barriers.
Multiplex Metabolic Rerouting
Simultaneous knockout of multiple genes in a single pathway. For example, disrupting starch synthesis (STA6) and alternative carbon sinks to redirect photosynthetic energy toward lipid production.
Conditional Knockout
Using inducible systems to study essential genes whose permanent loss would be lethal to the alga, allowing for temporal control over gene silencing.
Marker-Free Editing
Implementation of transient selection markers that can be removed post-editing, leaving a "clean" genome suitable for secondary modifications or industrial release.
1. Design & Synthesis
2. RNP Delivery
3. Screening & Selection
4. Validation & Delivery
Bioinformatic selection of gRNAs optimized for the Chlamydomonas 64% GC-content. Synthesis of gRNAs and preparation of high-purity Cas9 or Cas12a protein.
Transformation of Chlamydomonas cell-wall-deficient strains (or chemically treated walled strains) via electroporation of pre-assembled RNPs.
Verification of indel sequences via Sanger sequencing or NGS. Functional validation (e.g., lipid profiling) and delivery of verified clones.
Silencing Avoidance
RNP delivery ensures that no foreign DNA is integrated into the nucleus, preventing the activation of algal gene silencing mechanisms.
Haploid Advantage
Working primarily with vegetative haploid cells allows for immediate phenotypic observation of the knockout without the need for backcrossing.
GC-Rich Expertise
Specialized nuclease variants and optimized buffers ensure high cutting efficiency even in the most challenging GC-rich genomic regions.
Fast Turnaround
Our optimized screening pipeline reduces the time from design to delivery, providing verified strains in as little as 12 weeks.
1. Why is RNP delivery better than plasmid delivery for Chlamydomonas?
Chlamydomonas is highly efficient at silencing integrated DNA. RNPs provide transient Cas9 activity and do not integrate into the genome, avoiding silencing and reducing long-term off-target risks.
2. How do you handle strains that have a robust cell wall?
We utilize specialized transformation techniques such as glass bead agitation or autolysin treatment to transiently remove or weaken the cell wall, allowing for efficient RNP entry.
3. Can you knockout multiple genes at once?
Yes, we offer multiplexed editing where multiple RNPs are delivered simultaneously. This is ideal for targeting multi-gene families or redundant enzymes in metabolic pathways.
4. How is the final knockout strain verified?
We perform PCR across the target site followed by Sanger sequencing to confirm the indel. For multiplexed or complex projects, Next-Generation Sequencing (NGS) is used for comprehensive verification.
5. Is the haploid nature of the vegetative cells beneficial for KO?
Absolutely. Since vegetative cells are haploid, only one allele needs to be disrupted to achieve a complete knockout, allowing for rapid screening and phenotypic characterization.
6. Do you offer chloroplast genome knockout?
Yes, we provide specialized chloroplast editing services using biolistic delivery, which is specifically suited for modifying photosynthetic and metabolic components within the plastid.
7. What are the common phenotypes you screen for?
Common screens include changes in chlorophyll fluorescence (Fv/Fm) for photosynthetic mutants, altered pigment profiles, starch/lipid content shifts, and changes in flagellar motility.
8. What is the typical lead time for a project?
A standard single-gene knockout project typically takes between 12 to 16 weeks, including gRNA validation, transformation, clonal isolation, and final genomic verification.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.